mRNA Adjuvant Boosts Immunity, Colossal Biosciences Sparks Skepticism Over Egg Tech, Pediatric Dexmedetomidine Boosts Cognition, FSU Breakthrough Synthesizes Marine Compounds, and more...

brief.news

20 May 2026

(0:10): Breakthrough mRNA Adjuvant Boosts T-Cell Responses, Shows Promise for Cancer Immunotherapy and Infectious Disease Vaccines(2:36): Colossal Biosciences' Moa Revival: Artificial Egg Technology Sparks Skepticism Despite Engineering Feats(4:29): Study Reveals Pediatric Sedation with Dexmedetomidine Linked to Better Long-Term Cognitive Outcomes(6:34): FSU Achieves Breakthrough in Synthesizing Marine Compounds for Cancer Drug Development(9:00): Glycan Atlasing Offers Breakthrough in Early Disease Detection and Diagnosis Through Sugar MappingTo subscribe visit https://www.brief.news.For more updates in your inbox each morning visit www.brief.news. Image credit: Time